U.S. flag

An official website of the United States government

NM_001184880.2(PCDH19):c.1178C>T (p.Pro393Leu) AND Developmental and epileptic encephalopathy, 9

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 14, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003509062.1

Allele description

NM_001184880.2(PCDH19):c.1178C>T (p.Pro393Leu)

Gene:
PCDH19:protocadherin 19 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_001184880.2(PCDH19):c.1178C>T (p.Pro393Leu)
HGVS:
  • NC_000023.11:g.100407420G>A
  • NG_021319.1:g.7854C>T
  • NM_001105243.2:c.1178C>T
  • NM_001184880.2:c.1178C>TMANE SELECT
  • NM_020766.3:c.1178C>T
  • NP_001098713.1:p.Pro393Leu
  • NP_001171809.1:p.Pro393Leu
  • NP_065817.2:p.Pro393Leu
  • LRG_843t1:c.1178C>T
  • LRG_843:g.7854C>T
  • LRG_843p1:p.Pro393Leu
  • NC_000023.10:g.99662418G>A
Protein change:
P393L
Molecular consequence:
  • NM_001105243.2:c.1178C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001184880.2:c.1178C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020766.3:c.1178C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Developmental and epileptic encephalopathy, 9 (DEE9)
Synonyms:
EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION; JUBERG-HELLMAN SYNDROME; PCDH19-Related X-Linked Female-Limited Epilepsy with Mental Retardation; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010246; MedGen: C1848137; Orphanet: 2076; OMIM: 300088

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004300140Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Nov 14, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Cognitive development in females with PCDH19 gene-related epilepsy.

Cappelletti S, Specchio N, Moavero R, Terracciano A, Trivisano M, Pontrelli G, Gentile S, Vigevano F, Cusmai R.

Epilepsy Behav. 2015 Jan;42:36-40. doi: 10.1016/j.yebeh.2014.10.019. Epub 2014 Dec 11.

PubMed [citation]
PMID:
25499160

Mosaicism and incomplete penetrance of PCDH19 mutations.

Liu A, Yang X, Yang X, Wu Q, Zhang J, Sun D, Yang Z, Jiang Y, Wu X, Wei L, Zhang Y.

J Med Genet. 2019 Feb;56(2):81-88. doi: 10.1136/jmedgenet-2017-105235. Epub 2018 Oct 4.

PubMed [citation]
PMID:
30287595
PMCID:
PMC6581080
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV004300140.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PCDH19 protein function. This missense change has been observed in individual(s) with PCDH19-related epilepsy (PMID: 25499160, 30287595). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 393 of the PCDH19 protein (p.Pro393Leu).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024